Clinical trial · Observational
Whole-body MRI for the Detection of Metastasis
NCT02183597CI-TRIAL-00023429WBMRIwithdrawnClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Metastases | Breast Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Advanced breast cancer
- description
- Women with advanced breast cancer
Primary outcomes (1)
- measure
- Number of metastasis in skeleton
- timeFrame
- Baseline and after 6 months
- description
- Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: \- Cancer patient Exclusion Criteria: * Poor general condition * Pacemaker or other MRI contraindications
References
Publications (0)
Data not yet available
No reference posted for this study.